CLL Defined

Published on

Topics include: Understanding

What is CLL?  How and where does it start?  Dr. Nicole Lamanna of Columbia University Medical Center and Dr. Michael Keating of MD Anderson Cancer Center answer these questions, offering a clear and basic definition.  Listen for Dr. Keating to share his insight about a possible future CLL vaccine.

Provided by CLL Global Research Foundation, which received support from AbbVie Inc., Genentech Inc., Gilead Sciences, Janssen Pharmaceuticals, Inc., Pharmacyclics, Inc. and Teva Pharmaceuticals.

View more programs featuring and

Produced in association with

Related Programs

How Is Immuno-Oncology Evolving?

The area of immuno-oncology continues to inspire excitement from cancer researchers. Dr. Michael Keating shares his thoughts.


Dr. Michael Keating: My Hopes for the Future of CLL

Dr. Michael Keating explores how far CLL research has come and explains why he predicts that in five years time, "80 to 90 percent of patients will be free of detectable leukemia."


Join Our Community Register for Events Read Our Latest Blog

Page last updated on February 19, 2016